CVRx Inc (CVRX)
13.91
-0.22
(-1.56%)
USD |
NASDAQ |
Nov 15, 16:00
13.99
+0.08
(+0.58%)
After-Hours: 20:00
CVRx Research and Development Expense (TTM): 10.57M for Sept. 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 10.57M |
| June 30, 2024 | 10.76M |
| March 31, 2024 | 11.27M |
| December 31, 2023 | 11.63M |
| September 30, 2023 | 12.44M |
| June 30, 2023 | 12.04M |
| March 31, 2023 | 11.11M |
| December 31, 2022 | 9.952M |
| Date | Value |
|---|---|
| September 30, 2022 | 8.703M |
| June 30, 2022 | 8.109M |
| March 31, 2022 | 8.009M |
| December 31, 2021 | 7.501M |
| September 30, 2021 | 6.214M |
| June 30, 2021 | 6.015M |
| March 31, 2021 | 5.891M |
| December 31, 2020 | 6.41M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
5.891M
Minimum
Mar 2021
12.44M
Maximum
Sep 2023
9.164M
Average
9.328M
Median
Research and Development Expense (TTM) Benchmarks
| NeuroOne Medical Technologies Corp | 5.731M |
| SINTX Technologies Inc | 8.045M |
| Nutriband Inc | 2.863M |
| enVVeno Medical Corp | 11.72M |
| Beyond Air Inc | 25.68M |